Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Catalysts Filings Track record Movers The Lead Compound

Home › Targets › KAT7

KAT7 (1 companies · 2 programs)

Companies with an active program directed at KAT7.

IDEAYA Biosciences, Inc. IDYA

IDE574 Phase 1
IDE574 — Breast Cancer Phase 1

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.